日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
Business / Industries

Stem cells offer ray of hope for healthy future

By Alfred Romann in Seoul For China Daily (China Daily) Updated: 2014-06-23 07:08

Regenerative medicine sector needs more financial support from private investors

One of the most important and innovative pharmaceutical companies in Asia has its headquarters in a busy neighborhood of Seoul, nestled between insurance companies and banks, and not far from Seoul National University.

Medipost Co Ltd, launched in 2000 to research and develop stem cell and regenerative medicine products, has emerged as a leader in the space, both regionally and globally. It took a dozen years for the company to launch its first product commercially: Cartistem used to treat repair cartilages in the knee.

Between its founding and its first product launch, Medipost issued new shares six times and split its stock once. It generated some further revenue, mostly by storing umbilical cord blood, using the blood to transplant stem cells, and later by out-licensing products.

But that income was tiny compared to the cost of developing its drugs. Improbably, it managed to attract enough investors to keep going and growing.

That investment is now starting to pay off. Cartistem is just one of three stem cell products approved for sale in South Korea, and Medipost might be the only public company in the country with global ambitions.

"There are not many companies that can deal with global development in the pharmerging market," said Jay Lee, a senior director at Medipost, speaking at a conference in South Korea last month.

The "pharmerging" markets are the emerging markets for pharmaceutical products. China is possibly the biggest, but there are quite a few of them in the region including South Korea and much of the Association of Southeast Asian Nations.

Even Japan, despite its large economy, is considered an emerging market in some ways because it is often years before drugs developed elsewhere make their way down to patients there due to conservative regulations.

But much is changing in the region, particularly in South Korea and Japan. Both countries are embracing often-controversial research into regenerative medicine, including stem cells.

"There is an exceptional example of a new approach in Japan. They are looking very much, as in South Korea, to develop the stem cell space," says Dianne Jackson-Matthews, an Australia-based director at ERA Consulting Group.

For the time being, government support is driving the growth of this particular industry. Private or institutional investors are not yet convinced that taking a risk on a company developing a drug using science few people understand is worthwhile.

Stem cells offer ray of hope for healthy future

Stem cells offer ray of hope for healthy future

 Stem Cell Industrial Park under construction in Wenjiang  Medical experts call for effective stem cell treatment regulation

Previous Page 1 2 3 Next Page

Hot Topics

Editor's Picks
...
...
主站蜘蛛池模板: 久久久精品中文字幕 | 午夜免费视频 | 日本久久精品 | 国产精品88 | 成年人香蕉视频 | 亚洲一区二区在线看 | 国产视频手机在线 | 美女视频一区二区 | 国产一区二区观看 | 亚洲国产精品99 | 老熟妇毛片 | 97超碰免费 | www.操.com | 久久久香蕉视频 | 四虎影院www | 懂色av一区二区三区蜜臀 | 蜜桃精品视频在线 | 九九热国产精品视频 | 亚洲国产精品视频 | 欧美午夜精品久久久久免费视 | 波多野结衣家庭教师 | 久久久久久久久久久久久久 | 欧日韩一区二区三区 | 亚洲第一视频网站 | 国产成人一区二区在线观看 | 亚洲性视频网站 | 天天透天天操 | 专干老肥女人88av | www.欧美色| 久久一区二区三区四区五区 | 国产精品一区二区三区在线 | 五月婷婷六月丁香综合 | 亚洲色域网 | 91一区二区三区在线观看 | 手机看片欧美日韩 | 天美传媒免费在线观看 | 亚洲一级特黄 | 色女人影院 | 91麻豆成人 | 国产在线成人 | 天堂av一区二区 |